Espero BioPharma CEO and BioFlorida Member Quang Pham selected as EY Entrepreneur Of The Year® 2017
Thursday, May 4, 2017
For immediate release
Espero BioPharma CEO and BioFlorida Member Quang Pham selected as
EY Entrepreneur Of The Year® 2017 Award finalist in Florida
JACKSONVILLE, Fla, May 4, 2017 – EY today announced that Quang Pham, Chief Executive Officer of Espero BioPharma, Inc., is a finalist for the Entrepreneur Of The Year® 2017 Award in Florida. The awards program, which is celebrating its 31st year, recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Mr. Pham was selected as a finalist by a panel of independent judges. Award winners will be announced at a special gala on June 23 at the Omni Orlando Resort at ChampionsGate.
“I am honored to be selected as a finalist for this prestigious award,” said Quang Pham, CEO of Espero. “Our team works diligently every day to bring the best in class medications to patients living with cardiovascular disease, the number one cause of death worldwide.” He was the BioFlorida Entrepreneur of the Year Award Recipient for 2016.
Under Pham’s leadership, Espero has secured three FDA-approved cardiovascular drugs: NITROLINGUAL® PUMPSPRAY, GONITROTM (acute relief of an attack or prophylaxis of angina pectoris), DURLAZA® (to reduce the risk of heart attacks, strokes, or death in high-risk patients such as those with diabetes and cardiovascular disease), tecarfarin (anti-coagulant) in Phase 3 and budiodarone (anti-arrhythmia) in Phase 2, pending the closing of the merger with Armetheon, Inc.
Now in its 31st year, the program has expanded to recognize business leaders in over 145 cities and more than 60 countries throughout the world.
Regional award winners are eligible for consideration for the Entrepreneur Of The Year National competition. Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced at the Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 18, 2017. The awards are the culminating event of the Strategic Growth ForumTM, the nation’s most prestigious gathering of high-growth, market-leading companies.
Founded and produced by Ernst & Young LLP in the US, the Entrepreneur Of The Year Awards are nationally sponsored in the US by SAP America, Merrill Corporation and the Ewing Marion Kauffman Foundation.
In Florida, sponsors also include PNC Bank and Vaco.
Espero is a commercial-stage cardiovascular biopharmaceutical company engaged in maximizing the commercial value of proven treatments that improve the quality of life for patients. Espero is focused on compounds with proven safety and efficacy administered via novel delivery solutions in the cardiovascular category. Through Jacksonville Pharmaceuticals, its wholly owned subsidiary, the company markets and distributes selected generic pharmaceutical products including the authorized generic version of Nitrolingual® Pumpspray (nitroglycerin lingual spray). On March 30, 2017, Espero Pharmaceuticals, Inc. and Armetheon, Inc. announced their intentions to merge in the second quarter of 2017.
About Entrepreneur Of The Year®
Entrepreneur Of The Year®, founded by EY, is the world’s most prestigious business awards program for entrepreneurs, chosen from an independent panel of judges including entrepreneurs and prominent leaders from business, finance, and the local community. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in over 145 cities and more than 60 countries. ey.com/eoy
About EY’s Growth Markets Network
EY’s worldwide Growth Markets Network is dedicated to serving the changing needs of high-growth companies. For more than 30 years, we’ve helped many of the world’s most dynamic and ambitious companies grow into market leaders. Whether working with international mid-cap companies or early stage, venture-backed businesses, our professionals draw upon their extensive experience, insight and global resources to help your business succeed. For more information, please visit us at ey.com/sgm or follow news on Twitter @EY_Growth.
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by Ernst & Young LLP, a member of the global EY organization that provides services to clients in the US. For more information, please visit ey.com.